This Article Full Text Full Text (PDF) All Versions of this Article: 28/11/1950    most recent ATVBAHA.107.161224v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schober, A. Search for Related Content PubMed PubMed Citation Articles by Schober, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Vascular Diseases Related Collections Chemokines in ATVB

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1950.)
© 2008 American Heart Association, Inc.

Brief Reviews

Chemokines in Vascular Dysfunction and Remodeling

Andreas Schober

From the Cardiology Unit, Medical Policlinic-City Center Campus, University of Munich, Germany.

Correspondence to Dr Andreas Schober, Cardiology Unit, Medizinische Poliklinik, University of Munich, Pettenkoferstraße 8a, 80336 Munich, Germany. E-mail andreas.schober{at}med.uni-muenchen.de

Series Editor: Christian Weber
ATVB In Focus

Chemokines in Atherosclerosis, Thrombosis, and Vascular Biology

Vascular remodeling stands for structural changes of the vessel wall in response to various noxious stimuli, which results in reorganization of the vessel wall architecture. Luminal narrowing because of neointima formation and constrictive remodeling leading to hypoperfusion is the most relevant clinical effect. Smooth muscle cell (SMC) accumulation, inflammatory cell recruitment, and endothelial regeneration are the critical parts in obstructive vascular remodeling. Chemokines and chemokine receptors have a great impact on initiating and progressing neointimal formation by controlling each step of the remodeling process. SDF-1 regulates vascular repair by CXCR4-dependent smooth muscle progenitor cell recruitment, which contributes to the maladaptive response to injury. The three distinct chemokine-chemokine receptor pairs MCP-1/CCR2, RANTES/CCR5, and Fractalkine/CX₃CR1 direct lesional leukocyte infiltration. In addition MCP-1/CCR2 and Fractalkine/CX₃CR1 increase neointimal SMC expansion. In contrast, KC/Gro- supports endothelial recovery through CXCR2, which attenuates neointima formation. These findings highlight the importance to characterize specific functions of the chemokine network to enable therapeutic intervention.

This article has been cited by other articles:

				H. S. K. Potula, D. Wang, D. Van Quyen, N. K. Singh, V. Kundumani-Sridharan, M. Karpurapu, E. A. Park, W. C. Glasgow, and G. N. Rao Src-dependent STAT-3-mediated Expression of Monocyte Chemoattractant Protein-1 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Vascular Smooth Muscle Cell Migration J. Biol. Chem., November 6, 2009; 284(45): 31142 - 31155. [Abstract] [Full Text] [PDF]

				M.-L. Sung, C.-C. Wu, H.-I Chang, C.-K. Yen, H. J. Chen, J.-C. Cheng, S. Chien, and C.-N. Chen Shear Stress Inhibits Homocysteine-Induced Stromal Cell-Derived Factor-1 Expression in Endothelial Cells Circ. Res., October 9, 2009; 105(8): 755 - 763. [Abstract] [Full Text] [PDF]

				D. L. Burke, M. G. Frid, C. L. Kunrath, V. Karoor, A. Anwar, B. D. Wagner, D. Strassheim, and K. R. Stenmark Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L238 - L250. [Abstract] [Full Text] [PDF]

				G. Grassia, M. Maddaluno, A. Guglielmotti, G. Mangano, G. Biondi, P. Maffia, and A. Ialenti The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice Cardiovasc Res, July 31, 2009; (2009) cvp238v2. [Abstract] [Full Text] [PDF]